1-166862213-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000367874.5(TADA1):āc.530A>Gā(p.Tyr177Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000502 in 1,613,372 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000367874.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TADA1 | NM_053053.4 | c.530A>G | p.Tyr177Cys | missense_variant | 5/8 | ENST00000367874.5 | NP_444281.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TADA1 | ENST00000367874.5 | c.530A>G | p.Tyr177Cys | missense_variant | 5/8 | 1 | NM_053053.4 | ENSP00000356848 | P1 | |
TADA1 | ENST00000467021.1 | n.1004A>G | non_coding_transcript_exon_variant | 1/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251160Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135740
GnomAD4 exome AF: 0.0000493 AC: 72AN: 1461058Hom.: 0 Cov.: 33 AF XY: 0.0000426 AC XY: 31AN XY: 726858
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | The c.530A>G (p.Y177C) alteration is located in exon 5 (coding exon 5) of the TADA1 gene. This alteration results from a A to G substitution at nucleotide position 530, causing the tyrosine (Y) at amino acid position 177 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at